Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection

Journal of Infectious Diseases

Volumn 187, Issue 9, 2003, Pages 1397-1403

  Kwa, David ^a   Vingerhoed, Jose ^a   Boeser, Brigitte ^a   Schuitemaker, Hanneke ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOGENIC EFFECT; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURVIVAL; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; PHYTOHEMAGGLUTININS; RECEPTORS, CCR5; VIRUS REPLICATION;

EID: 0038555816     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374650     Document Type: Article

References (31)

1. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992; 66:1354-60.
2. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-8.
3. Deng HK, Liu R, Ellmeier W, et al. Identification of the major coreceptor for primary isolates of HIV-1. Nature 1996; 381:661-6.
4. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-73.
5. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-48.
6. - cell depletion and progression to AIDS. Ann Intern Med 1993; 118:681-8.
7. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-7.
8. Tersmette M, Gruters RA, De Wolf F, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989; 63:2118-25.
9. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. J Infect Dis 1993; 168:1374-9.
10. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993; 67:1772-7.
11. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185:621-8.
12. + T cell decline. Proc Natl Acad Sci USA 2000; 97:1269-74.
13. + T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999; 73:6430-5.
14. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997; 94:1925-30.
15. van Rij RP, Blaak H, Visser JA, et al. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000; 106:1039-52.
16. Grivel J-C, Margolis DB. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999; 5:344-6.
17. + T-cell subsets are determined only by co-receptor expression. J Virol 2001; 75:10455-9.
18. Berkowitz RD, Alexander S, Bare C, et al. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol 1998; 72:10108-17.
19. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature 1996; 383:768.
20. Blaak H, Brouwer M, Ran LJ, De Wolf F, Schuitemaker H. In vitro replication kinetics of HIV-1 variants in relation to viral load in long-term survivors of HIV-1 infection. J Infect Dis 1998; 177:600-10.
21. De Roda Husman AM, van Rij RP, Blaak H, Broersen S, Schuitemaker H. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for HIV-1 disease progression. J Infect Dis 1999; 180:1106-15.
22. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992; 6:49-54.
23. Quinones-Mateu ME, Ball SC, Marozsan AJ, et al. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol 2000; 74:9222-33.
24. Asjo B, Albert J, Karlsson A, et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986; 2:660-2.
25. Kreisberg JF, Kwa D, Schramm B, et al. Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol 2002; 75:8842-7.
26. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994; 169:968-74.
27. Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med 1999; 5:535-41.
28. Rudensey LM, Kimata JT, Benveniste RE, Overbaugh J. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 1995; 207:528-42.
29. van't Wout AB, Blaak H, Ran LJ, Brouwer M, Kuiken C, Schuitemaker H. Evolution of syncytium inducing and non-syncytium inducing biological virus clones in relation to replication kinetics during the course of HIV-1 infection. J Virol 1998; 72:5099-107.
30. Scoggins RM, Taylor JR, Patrie J, van't Wout AB, Schuitemaker H, Camerini D. Pathogenesis of primary R5 HIV-1 clones in SCID-hu mice. J Virol 2000; 74:3205-16.
31. Berkowitz RD, van't Wout AB, Kootstra NA, et al. R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. J Virol 1999; 73:7817-22.